A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)
Abroad (travel likely)RecruitingPHASE2
Conditions
Immune Thrombocytopenia · Treatment
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
Contact: Principal Investigator (Lei Zhang, MD)
Study leads
Lei Zhang, MD
Principal Investigator
Chinese Academy of Medical Science and Blood Disease Hospital